The JAK2/STAT3 signaling pathway is required for growth of CD44(+) CD24(−) stem cell-like breast cancer cells, particularly in basal-like breast cancers and is independently associated with breast cancer metastasis and poor prognosis32,33. This evidence concerns the gene STAT3 and breast cancer.